Overview

• Judges held Bayer HealthCare, Sandoz and Viatris Santé liable for “lack of information” after a patient developed multiple non-cancerous brain tumors following over 20 years of Androcur use
• Medical records show the 55-year-old patient began suffering visual disturbances, memory loss and severe fatigue after her 2013 diagnosis of meningiomas
• Court documents note a scientific article first warned of the cyproterone acetate-tumor link in 2008 and that the association was firmly established by 2018
• Liability was shared jointly with the prescribing physician and dispensing pharmacist, and the decision orders about €325,000 in solidarity, 25% of which is due immediately
• Bayer has announced plans to appeal the ruling, and plaintiff’s counsel predicts the decision will spur further compensation claims against Androcur manufacturers